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The nutrient sensor, O-linked N-acetylglucosamine (O-GlcNAc), cycles on and off nuclear and cyto-
solic proteins to regulate many cellular processes, including transcription and signaling. Dysregulated
O-GlcNAcylation and its interplay with phosphorylation contribute to the etiology of diabetes, cancer, and
neurodegeneration. Herein, we review recent findings about O-GlcNAc’s regulation of cell physiology.Introduction
Complexmolecular mechanisms ensure cellular homeostasis be-
tween nutrient sensing and energy metabolism. Strong evidence
frommany laboratoriessupportsa role for thehexosaminebiosyn-
theticpathway (HBP)and its endproduct,UDP-GlcNAc, as impor-
tant nutrient sensors (Bond and Hanover, 2013; Hart et al., 2011;
Vaidyanathan et al., 2014). The biosynthesis of UDP-GlcNAc is
regulated by nearly every major metabolic pathway (Figure 1A).
Production of fructose-6-phosphate by the glycolytic pathway is
the first committed step of the HBP. Depending upon the cell
type andmetabolic state, about 2%–5%of theglucose that enters
the cell is directed to the HBP to make UDP-GlcNAc. Amino acid
metabolism is linked to flux through the HBP at several steps:
via glucose through gluconeogenesis, via glutamine serving as
the nitrogen donor to form glucosamine-6-phosphate, and via
acetyl-CoA serving as the donor for acetylation of glucosamine-
6-phosphate throughketogenesis. Fatty acidmetabolism is linked
to the HBP via acetyl-CoA as well. The latter is not only essential
to fatty acid metabolism but also serves to balance flux between
carbohydrates and fatty acids. UTP, which serves as the donor
to form UDP-GlcNAc, links flux through the HBP to both energy
and nucleotide metabolism. Thus, UDP-GlcNAc sits at a major
nexus of cellular metabolic pathways and is responsive to flux
through them.
Although UDP-GlcNAc is used for the synthesis of secreted
or membrane glycoproteins, where its concentration appears
to control branching of complex glycans, the nucleotide sugar
also serves as the donor substrate for O-GlcNAc trans-
ferase (OGT)-catalyzed O-GlcNAcylation of myriad nuclear,
cytoplasmic, and mitochondrial proteins. Although discovered
in the early 1980s,O-GlcNAcylation’s key roles in cellular regula-
tion are only more recently being widely understood. Unlike
phosphorylation that requires over 600 kinases and phospha-
tases in humans, only two genes encode the enzymes that cata-
lyze O-GlcNAc cycling. OGT catalyzes the transfer of a single
O-GlcNAc moiety from UDP-GlcNAc to a serine or threonine
residue in proteins, whereas O-GlcNAcase (OGA) removes the
O-GlcNAc. OGT enzymatic activity is not only highly responsive
to UDP-GlcNAc across a very broad range of concentrations,
but also its substrate specificity is dependent upon the concen-
tration of the nucleotide sugar (Shen et al., 2012). UDP-GlcNAc
concentrations vary dramatically between tissues, during
differentiation, during inflammation, and in response to stimuli208 Cell Metabolism 20, August 5, 2014 ª2014 Elsevier Inc.and nutrient availability. OGT is therefore a ‘‘control center’’
that integrates metabolic flux to send signals to effectors via
O-GlcNAcylation.
This short review cannot summarize all the extensive work
about O-GlcNAcylation of proteins and their regulation (we refer
interested readers to recent comprehensive reviews: Bond and
Hanover, 2013; Hart et al., 2011; Ma and Hart, 2013; Vaidyana-
than et al., 2014). Here we discuss only very recent findings
that illustrate how OGT and O-GlcNAcylation regulate key
downstream effectors to modulate cell physiology in response
to nutrients.
Nutrient Regulation of Signaling via O-GlcNAcylation
Crosstalk between protein phosphorylation andO-GlcNAcylation
at the same or proximal sites on proteins or by one modification
regulating the other’s cycling enzymes is extensive and well
documented (Figure 1B). Competition for the same or nearby
site has been previously described for c-Myc, estrogen receptor
b (ERb), C-terminal domain (CTD) of the RNA polymerase II, p53,
forkhead boxO1 (FoxO1), calcium/calmodulin-dependent protein
kinase IV (CamKIV), casein kinase 2 (CK2), period 2 (PER2), and
many other proteins. The interplay between O-GlcNAcylation
and phosphorylation can also occur at more distant sites on
proteins, which has been previously shown for cytokeratins.
Both O-GlcNAc and O-phosphate may also exist simultaneously
on the same protein at different sites, as seen on insulin receptor
substrate (IRS), cardiac myosin light chain, or AMP-activated
protein kinase (AMPK). Finally, phosphorylation can enhance
O-GlcNAcylation, such as has been shown for cAMP response
element-binding protein (CREB) (Bullen et al., 2014; Hart et al.,
2011; Kaasik et al., 2013; Tarrant et al., 2012).
Recent glycomic and phosphoproteomic analyses indicate
that the interplay betweenO-GlcNAcylation and phosphorylation
are more extensive and complex than previously anticipated.
Both OGT and OGA have been found in complexes with
kinases or phosphatases, suggesting that they are acting within
molecular complexes able to both phosphorylate and/or
O-GlcNAcylate. Integration of cell stimuli and signals, as well
as nutrient availability, determines which posttranslational mod-
ifications (PTMs) are added to polypeptides (Figure 1B).
Numerous kinases belonging to various signaling path-
ways are O-GlcNAcylated (G. Han, J. Neiswinger, S.H.,
K. Sakabe, I. Tchernyshyov, J.E. Van Eyk, H. Zhu, and G.W.H.,
Figure 1. O-GlcNAcylation Is a Key Link
between Nutrient Sensing and Signaling
(A) The biosynthesis of UDP-GlcNAc by HBP in-
tegrates the flux through many metabolic path-
ways linked to nutrient intake. Variation in part or
all of these pathways directly impacts the flux
through HBP, the production of UDP-GlcNAc, and
the rate of O-GlcNAcylation.
(B) Schematic depicting the relationship of
O-GlcNAcylation with phosphorylation for a single
protein.
(C) Depending upon UDP-GlcNAc concentra-
tion, OGT modifies specific kinases. Regulation of
substrate specificity and/or activity of upstream
kinases by O-GlcNAcylation have profound ef-
fects on signaling and cellular physiology.
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by O-GlcNAcylation. Modulation of upstream kinases by O-
GlcNAcylation may drastically change the activation or inhibition
of downstream signaling pathways (Figure 1C).O-GlcNAcylation
of CamKIV at S189 inhibits its phosphorylation at T200 and
blocks its ability to bind ATP and to catalyze phosphorylation
(Hart et al., 2011). Since the Km for UDP-GlcNAc of OGT
with CamKIV is over 20 mM, it was proposed that in vivo O-
GlcNAcylation of CamKIV could vary significantly in response
to the rate of HBP flux (Shen et al., 2012). Calcium/Calmodulin-
dependent protein kinase II (CaMKII) is a multifunctional serine/
threonine kinase important for a variety of cellular functions,
including cell division, differentiation, cardiac contraction, and
synaptic plasticity. During hyperglycemia, as occurs in diabetes,
O-GlcNAcylation of CaMKII is increased in the heart and brain of
rats and humans. ItsO-GlcNAcylation at S279 leads to an auton-
omous constitutive activation even after Ca2+ concentration de-Cell Metabolism 2clines (Erickson et al., 2013), contributing
to diabetic cardiomyopathy. Recently,
it has been shown that CaMKII is acti-
vated by glucagon and fasting in vivo in
a calcium- and IP3R-dependent manner.
Activated CaMKII stimulates hepatic
glucose production through FoxO1 phos-
phorylation. In obese mice, hepatic
CaMKII remains activated and medi-
ates hepatic glucose production (Ozcan
et al., 2012). Owing to the tight relation-
ship between obesity, type II diabetes
and O-GlcNAcylation, it is possible
that CaMKII O-GlcNAcylation might also
contribute to the abnormal enhanced
hepatic glucose production associated
with diabetes and obesity, as has already
been shown for O-GlcNAcylation of
PPARg coactivator-1-alpha (PGC-1a),
FoxO1, and CREB-regulated transcrip-
tion coactivator 2 (CRTC2) transcription
factors. O-GlcNAcylation also controls
the substrate specificity of certain ki-
nases. CK2 is a serine/threonine kinase
that regulates cell physiology via the
phosphorylation of hundreds of proteinsinvolved in several major cellular processes such as cell cycle,
apoptosis, or cell differentiation. Although its regulation remains
poorly understood, it has been shown that the CK2a subunit is
O-GlcNAcylated at S347. Thismodification inhibits its phosphor-
ylation at T344 by Cdk1/Cyclin B and impairs its stabilization.
In vitro assays using protein microarrays found the surprising
result that although O-GlcNAcylation of CK2a doesn’t affect
its catalytic activity, it does regulate its substrate specificity (Tar-
rant et al., 2012). In vitro analyses of the OGT affinity toward CK2
suggest that its substrate selectivity may be nutrient sensitive
depending on its O-GlcNAcylation state (Lubas and Hanover,
2000).
In turn, there is evidence showing that enzymes that govern
O-GlcNAc cycling are substrate for kinases. Although OGT and
OGA are both phosphorylated, the role of the phosphorylation
of OGA remains unknown. Phosphorylation by insulin receptor,
CaMKIV, glycogen synthase kinase 3 beta (GSK3b), and AMPK0, August 5, 2014 ª2014 Elsevier Inc. 209
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ners and substrates (Bullen et al., 2014; Hart et al., 2011; Kaasik
et al., 2013). Phosphorylation and O-GlcNAcylation are in
competition for the modification of the residues S3 or S4 of
OGT, and it has been shown that phosphorylation by GSK3b at
these residues enhances OGT activity (Kaasik et al., 2013).
AMPK is an energy sensor protein kinase activated in response
to reduction of intracellular ATP levels. AMPK regulates
hundreds of substrates involved in energy metabolism by phos-
phorylation. It was recently shown that T444 of OGT is phosphor-
ylated by AMPK, and it appears that this modification regulates
OGT substrate selectivity (Bullen et al., 2014). Considering that
the activity of AMPK is positively regulated by O-GlcNAcylation
(Xu et al., 2014), these results suggest a regulatory feedback
control of AMPK through O-GlcNAcylation, giving a key role to
OGT/AMPK in the regulation of energy metabolism.
While there is still much to learn, it is already clear that nutrient
regulation of signaling pathways via O-GlcNAcylation impacts
nearly all regulatory mechanisms and cellular physiology.
Fundamental Importance of O-GlcNAcylation to
Transcription
While regulation of gene expression by hormones, growth fac-
tors, and tissue-specific factors is fairly well established, the
regulation of gene expression by nutrients is not well under-
stood. The first evidence linkingO-GlcNAcylation and chromatin
regulation emerged in the late 1980s. OGT andO-GlcNAcylation
were shown to be highly abundant on chromatin, associatedwith
transcriptionally active loci on polytene chromosomes in Droso-
philia, and the CTD of a subset of RNA polymerase is extensively
O-GlcNAcylated. More recently, Ogt was shown to be a poly-
comb gene. The polycomb group proteins aremaster regulators,
repressing the expression of large sets of genes that control
tissue patterning during development. In 2011, Myers et al.
confirmed the link between OGT and polycomb group proteins
in mammals by showing that the polycomb repressive complex
2 is required to maintain normal levels of OGT and for correct
cellular distribution of O-GlcNAcylation (Myers et al., 2011).
Deep sequencing technology established that OGT, OGA,
and O-GlcNAcylation are enriched at the active site of transcrip-
tion in thousands of genes in both human and in C. elegans
(Deplus et al., 2013; Love et al., 2010). O-GlcNAcylation regu-
lates many RNA polymerase II transcription factors. Depending
upon the transcription factor, the sugar modification regulates
their DNA binding activity (e.g., c-Rel, p53, pancreatic-duodenal
homeobox factor1), transcriptional activity (e.g., c-Myc, FoxO1,
CREB), and/or stability (e.g., mER-b, p53, d-lactoferrin,
b-catenin) (Bond and Hanover, 2013; Hardiville´ et al., 2010; Oliv-
ier-Van Stichelen et al., 2014).
O-GlcNAcylation also regulates the basal transcriptional ma-
chinery. Nearly all of the components of the basal transcription
machinery in mammals are modified by O-GlcNAc. The CTD of
RNA polymerase II is O-GlcNAcylated at the preinitiation step
of the transcription cycle, and the sugar modification is recip-
rocal to its phosphorylation, which is required for elongation
(Figure 2). O-GlcNAcylation occurs during the preinitiation com-
plex assembly and may regulate the initiation of transcription on
a multitude of genes in higher eukaryotes (Bond and Hanover,
2013).210 Cell Metabolism 20, August 5, 2014 ª2014 Elsevier Inc.Epigenetic modifications are heritable changes in chromatin
structure that govern temporal and spatial gene expression.
O-GlcNAcylation is not only part of the histone code but also in-
fluences other epigenetic modifications, such as DNA or histone
methylation. All four subunits of the core histones are O-
GlcNAcylated. Some sites of modification are known: H2A at
T101, H2B at S36 and S112, H3 at T32, and H4 at S47 (Vaidya-
nathan et al., 2014). Histone O-GlcNAcylation is increased dur-
ing the G1 phase of the cell cycle, declines during S phase,
and increases through G2 and mitosis phases to drop at M/
G1. Although the role of sugar on histone subunits remains
poorly understood, some of the O-GlcNAcylation sites directly
interact with DNA. O-GlcNAcylation of S112 of histone H2B
serves as the docking site for the ubiquitin ligase that modifies
H2B K120, which is a transcriptionally active gene mark
(Vaidyanathan et al., 2014). H2B ubiquitination and its ubiqui-
tination complex stimulate H3K4me3 through the SET1/
COMPASS complex. Host cell factor 1 (HCF-1) is an extensively
O-GlcNAcylated (19 known attachment sites) component of
SET1/COMPASS. OGT not only O-GlcNAcylates HCF-1, but
also acts as a unique protease to cleave the protein into its func-
tional fragments by a totally novel proteasemechanism involving
UDP-GlcNAc in the reaction mechanism (Lazarus et al., 2013).
Methylation of cytosine is another key epigenetic event crit-
ical for various cellular processes and is often associated with
transcription repression. Ten-eleven translocation (Tet) family
proteins are evolutionarily conserved dioxygenases that convert
5-methylcytosine (5mC) to 5-hydroxylmethylcytosine (5hmC).
Hydroxylmethylation of CpG-rich DNA promotes DNA deme-
thylation. Tet1, Tet2, and Tet3 interact strongly with OGT and
undergo O-GlcNAcylation (Chen et al., 2013; Deplus et al.,
2013; Shi et al., 2013a; Zhang et al., 2014). Mutation of Tet1
O-GlcNAc sites stabilizes Tet1, and the knockdown of OGT
by siRNA reduces the amounts of Tet1 and 5hmC on Tet1 target
genes (Shi et al., 2013a). Interaction between Tet3 and OGT
drives Tet3 out of the nucleus, concomitant with decreased
5hmC on DNA. Under pathologic glucose concentrations
(25 mM), Tet3 exhibits a cytoplasmic localization, and the
HBP inhibitor deoxynorleucine (DON) increases DNA 5hmC
content (Zhang et al., 2014). Conversely, Tet2 and Tet3 colocal-
ize with OGT at promoters, clustered around the transcription
start sites and CpG islands, and they overlap at promoters
with H3K4me3 (Chen et al., 2013; Deplus et al., 2013). Deple-
tion of Tet2 reduces O-GlcNAcylation of H2B at S112, sug-
gesting that Tet2 targets OGT to the nucleosome for H2B
O-GlcNAcylation (Chen et al., 2013), supporting the link be-
tween DNA methylation and the histone code through OGT
and O-GlcNAcylation. Taken together, these studies reveal a
central role of OGT and O-GlcNAcylation in basal and gene-
specific transcription, as well as in the epigenetic modifications
on DNA and histones (Figure 2).
O-GlcNAcylation and Cell Physiology
To maintain proper homeostasis, cell physiology has to adapt
to fluctuations in nutrient intake. Cell proliferation, for instance,
must be regulated in response to nutrient levels to ensure that
sufficient materials are synthesized to generate viable daughter
cells. O-GlcNAcylation is intimately linked to the cell cycle
since it varies on many proteins all along the cell cycle, and its
Figure 2. Regulation of Gene Transcription
and Epigenetics by O-GlcNAcylation
O-GlcNAc cycling on gene-specific transcription
factors and components of the basal transcrip-
tional machinery regulates gene activation. Sp1 is
one of the most extensively modified transcription
factors. The CTD of the RNA polymerase II (RNAP
II) is itself O-GlcNAcylated at the transcription
initiation step. The switch from transcription initi-
ation to elongation requires OGA activity to remove
the sugar. O-GlcNAcylation and OGT interaction
with master regulators of epigenetic marks also
switch on and off gene expression. The complex
comprised of Sin3A, HDAC, and OGT has
been proposed to inhibit transcription. OGT O-
GlcNAcylates and/or forms complexes with TETs
that drive DNA methylation. H2B O-GlcNAcylation
and ubiquitination are associated with transcrip-
tionally active loci. Insert emphasizes the role of
O-GlcNAcylation in the regulation of the histone
code.
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checkpoints (Hart et al., 2011).
Circadian rhythms are biological oscillations set up by
clock transcription factors for a period of about 24 hr. At the
cellular level, rhythms in nutrient intake must coincide with
fluctuations in gene expression for proper homeostasis. Not sur-
prisingly, nutrient regulation of circadian rhythms is linked to
O-GlcNAcylation. Protein O-GlcNAcylation and OGT protein
levels peak in the middle of the dark phase in mouse heart.
OgtmRNA levels increased 2 hr before dark, suggesting a regu-
lation of OGT expression by the circadian transcription factors
(Durgan et al., 2011). In the primary feedback loop, the posi-Cell Metabolism 2tive elements CLOCK and aryl hydro-
carbon receptor nuclear translocator-like
(BMAL1) initiate transcription of targeted
genes, including PER and cryptochrome
(CRY) genes. In return, negative feedback
is achieved by PER and CRY repres-
sing transcriptional activity of CLOCK/
BMAL1. BMAL1, CLOCK, PER1, and
PER2 are all O-GlcNAcylated (Durgan
et al., 2011; Kaasik et al., 2013).
BMAL1 and PER1 appeared to be O-
GlcNAcylated with a peak in the middle
of the dark phase in mouse heart (Durgan
et al., 2011). O-GlcNAcylation stabilizes
BMAL1 and CLOCK by inhibiting their
ubiquitination, which promotes expres-
sion of their target genes (Li et al., 2013).
PER2 can be O-GlcNAcylated at ten
different residues, and phosphorylation
at S662 inhibits its O-GlcNAcylation. The
reciprocal modification of PER2 S662
was shown to be at the core of regulation
of PER2 transcriptional repressor activity,
with a stronger repressor activity for the
O-GlcNAcylated isoform. The OGT inhib-
itor (Alloxan) or Ogt knockdown (siRNA
and Ogt conditional KO mice) shortenedthe circadian rhythm, while the OGA inhibitor (PUGNAC) length-
ened the circadian rhythmicity of PER2-luc oscillation (Durgan
et al., 2011; Kaasik et al., 2013), suggesting that the circadian
rhythm is adjusted by O-GlcNAcylation through PER2. Elevated
glucose significantly prevents phosphorylation of PER2, even
under OGA overexpression (Kaasik et al., 2013), and knockdown
of glutamine-fructose-6-phosphate aminotransferase 1 or Ogt
reduces expression of BMAL1 and CRY1 (Li et al., 2013). These
studies suggest that nutrient sensing by the HBP entrains circa-
dian rhythm via O-GlcNAcylation of the core circadian clock
transcription factors. Likewise, circadian oscillation is involved
in the control of nutrient homeostasis. A recent study showed0, August 5, 2014 ª2014 Elsevier Inc. 211
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leads to profound insulin resistance, hyperglycemia, and fat
accumulation in mice (Shi et al., 2013b). Since OGT modulates
the diurnal rhythm of glucose homeostasis (Li et al., 2013), it
is possible that O-GlcNAcylation could be the molecular link
between the circadian cycle, glucose homeostasis, and insulin
resistance.
O-GlcNAcylation regulates the insulin-signaling pathway at
several steps and has been shown to be involved in insulin resis-
tance. Downstream of the insulin-signaling cascade, hypergly-
cemia targets OGT to O-GlcNAcylate the transcription factor
CRTC2, increasing transcription of PGC-1a, which in turn inter-
acts with OGT to target the transferase to FoxO1, resulting in
its O-GlcNAcylation and enhanced transcriptional activity. This
cascade of events leads to inappropriate gluconeogenesis
associated with diabetes. Upstream of the insulin-signaling
pathway, OGT is activated by the insulin receptor, translocated
to the plasma membrane, and bound to phosphoinositides.
The O-GlcNAcylation of IRS1 inhibits phosphorylation required
for its interaction with the p85 regulatory subunit of phosphatidy-
linositol-3-kinase. The phospho-activation of protein kinase B
(AKT) at T308 is inhibited by its O-GlcNAcylation, leading to
downregulation of AKT function (Ma and Hart, 2013). GSK3b ac-
tivity is inhibited by AKT. Phosphorylation by GSK3b promotes
IRS1 degradation. GSK3b is O-GlcNAcylated and regulated by
the sugar modification (Lubas and Hanover, 2000). Interestingly,
the inhibitory phosphorylation at S9 of GSK3b shows a robust
circadian oscillation (Kaasik et al., 2013), and the stress-induced
S9 phosphorylation is delayed in an OGT null mouse cell line,
suggesting that O-GlcNAcylation may link circadian cycle, syn-
thesis of glycogen, and the insulin pathway through GSK3b.
Since OGT is activated by GSK3b phosphorylation, it is possible
that there may be a synergistic effect between O-GlcNAcylation
and GSK3b phosphorylation leading to insulin resistance.
O-GlcNAcylation also appears to regulate glucose meta-
bolism. All enzymes in the glycolytic pathway are substrates for
OGT. Yi et al. have shown that OGT overexpression or OGA inhi-
bition lowered the rate of glucose metabolism by decreasing
PFK1 activity. The authors mapped the O-GlcNAc site as S529,
a highly conserved residue known to be important for allosteric
regulation of PFK1 by fructose-2,6-bisphosphate. Inhibition of
PFK1 by O-GlcNAcylation redirects glucose flux from the glyco-
lytic pathway to theoxidative pentosephosphate pathway,which
has been proposed to benefit cancer cell growth (Yi et al., 2012).
Yi et al. also observed that increased O-GlcNAcylation reduced
cellular ATP concentrations, suggesting a relationship between
the sugar modification and energy production. This effect might
in part be due to decreased glycolytic flux, but not entirely, since
members of mitochondrial respiratory chain complexes are also
O-GlcNAcylated, such as the subunit NDUFA9 of complex I, core
1 and 2of complex III, and subunit COX I of complex IV.Hypergly-
cemia increases mitochondrial O-GlcNAcylation and leads to
impaired activity of complex I, III, and IV, which results in lower
cellular ATP content (Ma and Hart, 2013).
Reduced glucose metabolism contributes to the etiology of
neurodegeneration. Several studies have shown that reduced
O-GlcNAcylation of neural proteins, such as the tau protein, neu-
rofilaments, and synaptic vesicle proteins, and their concomitant
increased phosphorylation contribute directly to the etiology of212 Cell Metabolism 20, August 5, 2014 ª2014 Elsevier Inc.Alzhemier’s disease (AD). Inhibitors of OGA, which help maintain
or increase O-GlcNAcylation in the brain, may prove useful
for the treatment of AD (Hart et al., 2011). Clearly, understand-
ing more fully the ties that exist between nutrient sensing
by O-GlcNAcylation, phosphorylation, circadian rhythm regula-
tion, cell cycle, and metabolism will provide novel approaches
regarding treatment of obesity, diabetes, cancer, and AD.
Conclusions
It is clear that HBP,O-GlcNAcylation, andOGT act as keymolec-
ular components to sense nutrient availability. In normal physio-
logical conditions, OGT integrates those changes and transmits
the information to many effector proteins involved in myriad
cellular processes, such as transcription or signaling. OGT and
O-GlcNAcylation regulate cellular processes tomaintain homeo-
stasis at different states of nutrient availability. A growing body of
evidence links changes in nutritional status, cellular homeosta-
sis, and the establishment of chronic diseases beyond those
typically referred to as metabolic-related pathologies. Improper
nutrient homeostasis or nutrient excess leads to abnormal
O-GlcNAcylation of proteins with corresponding effects on
cell signaling and transcription. Prolonged nutrient excess leads
to abnormally high protein O-GlcNAcylation. Such hyper-
O-GlcNAcylation not only contributes to abnormal regulation of
phosphorylation signaling cascades, but also leads to incorrect
control of gene expression and chromatin architecture, all of
which contribute to nutrient toxicity, as is seen in diabetes. Like-
wise, defective glucose utilization, which results in abnormally
low O-GlcNAcylation, contributes directly to the onset of neuro-
degeneration. Faulty epigenetic information induced by deregu-
lation of O-GlcNAcylation could also be transmitted to the
daughter cells. The latter is particularly important in the light of
cancer etiology and the higher risk of cancer in individuals with
diabetes and obesity. Future research will need to elucidate
how the crosstalk between different PTMs on proteins works in
concert to modulate polypeptide functions in response to meta-
bolism and environmental clues. Clearly, understanding how the
nutrient sensor, O-GlcNAcylation, controls signaling pathways
and cellular processes and how it crosstalks with other PTMs
will be essential not only in understanding cellular physiology
but also in the development of new therapeutics.
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